TABLE 2.
Non-histone lactylation in brain diseases.
| Disease | Site of lactylation | Mechanism | Writer/Eraser | Ref |
|---|---|---|---|---|
| Ischemic stroke | ARF1 K73 | Exacerbated brain injury by limiting mitochondrial transfer | Unknown | Zhou et al. (2024a) |
| High-altitude cerebral edema | NuRD complex | Increased inflammation response under hypoxic conditions | Unknown | Jiang et al. (2024a) |
| Ocular neovascularization | YY1 K183 | Enhanced FGF2 transcription and promoted angiogenesis | p300 | Wang et al. (2023a) |
| Hypoxic-ischemic encephalopathy | cGAS K162 | Promoted the transformation of microglia into M1 type | Unknown | Wang et al. (2024c) |
| Chronic restraint stress | SNAP91 K885 | Promoted the formation of synaptic structures and neuronal activity | Unknown | Yan et al. (2024a) |
| Alzheimer’s disease | tau K677 | Promoted ferroptosis, decreased memory, and increased neuronal damage | Unknown | An et al. (2024) |